In the hospitals where DBS implantation is currently carried out, the key aspect of electrode implantation in patients relies on MRI and stereotactic techniques, and after these two localizations are completed, blind penetration under electrophysiological guidance is used to implant the electrodes, but physiological monitoring does not allow the distribution of blood vessels in the electrodes, but physiological monitoring does not allow the distribution of blood vessels in the electrodes, but physiological monitoring does not allow the distribution of blood vessels in the electrodes, but physiological monitoring does not allow the distribution of blood vessels in the electrodes. distribution. In this case when the electrode is implanted, the blood vessels passing through the surrounding area may be at risk of being punctured, which is one of the intracranial hemorrhage that is known as intraoperative risk. The hospital relies on the latest technology developed by the Bioengineering Medical Imaging Research Center – multimodal fusion hand X planning software (fully independent intellectual property rights), the application of this cutting-edge technology to solve the problem of intracranial hemorrhage caused by accidental injury to blood vessels due to the inability to understand the distribution of blood vessels on the brain surface and in the brain during the electrode implantation path in DBS. This technology is based on the high-end MRI equipment, relying on its special program design to complete the special vascular imaging technology, the important thing is that this imaging can be integrated into the surgical day positioning MRI, and fused with the surgical positioning system. This means that the cerebral vessels, target nuclei, and electrode pathways can be displayed in a single preoperative localization software. If the routinely calculated electrode implantation path map is fused with the cerebral vascular map and a vessel is found in the path, the electrode implantation path can be readjusted to avoid accidental injury to the vessel during electrode implantation and to give a safe and accurate implantation path. Although angiography (MRA) is generally possible with high-end MRI, it requires contrast injection. The special parameters developed by the Bioengineering Medical Imaging Research Center allow for 3D vascular imaging. The Parkinson’s Disease Treatment Center has applied this research to avoid the risk of intracranial hemorrhage as much as possible and to objectively evaluate the degree of neurological impairment in patients with Parkinson’s disease.